Addiction News

Fentanyl-involved overdose mortality rates were disproportionately high among American Indian or Alaska Native and Black individuals compared with other racial and ethnic groups, according to a research letter published in JAMA Psychiatry.

ORLANDO — Primary prevention programs for substance abuse should use strategies like those aimed at stress management and navigation of group dynamics, according to a speaker the Lifestyle Medicine Conference.

FDA has amended its Risk Evaluation and Mitigation Strategy to require that opioid manufacturers provide pharmacies and dispensaries with materials to facilitate the return of unused opioid analgesics, according to a press release.

Exercise interventions reduced daily alcohol dependence and significantly improved physical and mental health, like heart rate and anxiety, among patients with alcohol use disorder, according to a systematic review and meta-analysis.

Although state laws have expanded access to naloxone, overdose deaths among adolescents and young adults continue to climb, according to data published in JAMA Pediatrics.

The FDA approved RoxyBond 10 mg immediate-release tablet for the management of pain requiring an opioid analgesic for which there are no adequate alternative treatments, according to a press release from the manufacturer.

A community coalition-engaged intervention led to a statistically significant reduction in overdose deaths involving any opioid and psychostimulants other than cocaine, according to a study published in JAMA Network Open.

A new Lancet Public Health commission called for stronger policy and regulatory controls worldwide to reduce the impact of commercial gambling on public health and wellbeing.

Individuals receiving methadone for opioid use disorder had a lower risk for discontinuing treatment compared with the combination of buprenorphine and naloxone, study results published in JAMA showed.